Colossal Biosciences, which has brought to life a small pack of genetically modified dire wolves, has acquired cloning ...
Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and ...
Colossal Biosciences has expanded its efforts to save animals currently on the brink with its acquisition of the cloning ...
The $10 billion de-extinction firm, led by Ben Lamm, has acquired Austin’s Viagen Pets and Equine to advance its species preservation mission.
1don MSN
‘De-extinction’ startup Colossal Biosciences makes its first acquisition: a company that clones pets
Scooping up ViaGen Pets and Equine ostensibly adds more genetic firepower to Colossal’s arsenal. Terms of the acquisition ...
Viagen Pets and Equine is a biotechnology company that will produce genetic twins of customers' pets and livestock. But its conservation efforts are what attracted Colossal.
Colossal Biosciences, the world's de-extinction company, today announced its acquisition of Viagen Pets and Equine, the global leader and expert in animal cloning. Viagen provides genetic preservation ...
Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback